ArticleCureus2025
Parry-Romberg Syndrome Associated With En Coup De Sabre: A Clinical Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CT imaging-led diagnosis of Parry-Romberg syndrome: A case report and literature review highlighting craniofacial and neurologic involvement.Radiology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parry-Romberg syndrome (PRS), also known as progressive facial hemiatrophy, is a rare neurocutaneous disorder characterized by progressive, unilateral atrophy of the facial tissues. It usually appears during childhood or early adulthood; however, adult-onset cases are increasingly being recognized. PRS significantly overlaps with localized scleroderma, especially the en coup de sabre (ECDS) subtype, indicating a common pathophysiological mechanism. We present a 52-year-old female patient with adult-onset PRS associated with ECDS. The patient was first diagnosed with localized scleroderma in 1999, when she developed subtle atrophic changes in the right side of her face. Over two decades, the atrophy gradually advanced, leading to marked facial asymmetry. Re-evaluation in 2023 showed right hemifacial atrophy with a linear "sword stroke" lesion over the forehead that is a characteristic of ECDS. Laboratory tests, imaging, ophthalmologic evaluation, and skin biopsies confirmed PRS with linear scleroderma. To address the progressive functional and aesthetic impairments, systemic treatment with methotrexate was initiated to halt disease progression, with regular follow-ups scheduled for monitoring. This rare case of adult-onset PRS evolving from localized scleroderma highlights the need for high clinical suspicion in adults with progressive hemifacial atrophy, especially with ECDS. Early diagnosis and timely immunosuppressive treatment are crucial to limit disease progression and maximize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.